Department of Paediatrics, The Medical University of Warsaw, Dzialdowska 1, 01-184 Warsaw, Poland.
J Am Coll Nutr. 2010 Oct;29(5):443-54. doi: 10.1080/07315724.2010.10719881.
To systematically evaluate the effects of n-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) supplementation of pregnant and/or lactating women on the neurodevelopment and visual function of their children.
Systematic review. Randomized controlled trials (RCTs) comparing n-3 LCPUFA maternal supplementation were identified through electronic databases (MEDLINE, EMBASE, the Cochrane Library) and the references of reviewed articles.
Overall, 13 publications, some with important methodological limitations, were included. With regard to supplementation during pregnancy, among 3 RCTs that evaluated this intervention, 1 RCT (n = 72) showed significantly better eye and hand coordination assessed with the Griffiths Mental Development Scales at 30 months of age. Another RCT (n = 29) demonstrated an effect of n-3 LCPUFA supplementation on the cloth step of intentional solutions of the 2-step problem-solving test. No other effects were demonstrated. There was no consistent effect of n-3 LCPUFA supplementation during pregnancy on the children's visual acuity. With regard to supplementation during lactation, among 3 RCTs that assessed this intervention, 1 RCT (n =133) showed significant improvement on the Bayley Psychomotor Development Index in 30-month-old children; however, there was no influence of such supplementation on the results of different tests performed in the same group of children or in others. There was no consistent effect of n-3 LCPUFA supplementation during lactation on the children's visual function. Supplementation during pregnancy and lactation (3 RCTs) did not affect child neurodevelopment assessed up to 7 years of age.
Evidence from RCTs does not demonstrate a clear and consistent benefit of n-3 LCPUFA supplementation during pregnancy and/or lactation on child neurodevelopment and visual acuity. These results should be interpreted with caution due to methodological limitations of the included studies.
系统评估孕妇和/或哺乳期妇女补充长链 n-3 多不饱和脂肪酸(n-3 LCPUFA)对其子女神经发育和视觉功能的影响。
系统评价。通过电子数据库(MEDLINE、EMBASE、Cochrane 图书馆)和综述文章的参考文献,确定了比较 n-3 LCPUFA 母体补充的随机对照试验(RCT)。
共有 13 篇出版物,其中一些存在重要的方法学局限性,被纳入研究。关于妊娠期间的补充,在评估该干预措施的 3 项 RCT 中,1 项 RCT(n=72)显示 30 个月龄时使用 Griffiths 精神发育量表评估的眼手协调能力显著改善。另一项 RCT(n=29)表明 n-3 LCPUFA 补充对 2 步解决问题测试的故意解决的布步有影响。未显示出其他影响。妊娠期间补充 n-3 LCPUFA 对儿童视力没有一致的影响。关于哺乳期的补充,在评估该干预措施的 3 项 RCT 中,1 项 RCT(n=133)显示 30 个月龄儿童的贝利精神运动发育指数有显著改善;然而,这种补充对同一组儿童或其他儿童进行的不同测试结果没有影响。哺乳期补充 n-3 LCPUFA 对儿童视觉功能没有一致的影响。妊娠和哺乳期补充(3 项 RCT)并未影响 7 岁以下儿童的神经发育。
来自 RCT 的证据表明,孕妇和/或哺乳期补充 n-3 LCPUFA 对儿童神经发育和视力没有明确和一致的益处。由于纳入研究的方法学局限性,应谨慎解释这些结果。